These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 316311)

  • 1. Surgery in von Willebrand's disease.
    Nilsson IM; Bergentz SE; Larsson SA
    Ann Surg; 1979 Dec; 190(6):746-52. PubMed ID: 316311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemophilia in Sweden. Studies on demography of hemophilia and surgery in hemophilia and von Willebrand's disease.
    Larsson SA
    Acta Med Scand Suppl; 1984; 684():1-72. PubMed ID: 6611018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease.
    Franchini M; Rossetti G; Tagliaferri A; Pattacini C; Pozzoli D; Lippi G; Manzato F; Bertuzzo D; Gandini G
    Haematologica; 2003 Nov; 88(11):1279-83. PubMed ID: 14607757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open-heart surgery in von Willebrand's disease.
    Aris A; Pisciotta AV; Hussey CV; Gale H; Lepley D
    J Thorac Cardiovasc Surg; 1975 Feb; 69(2):183-7. PubMed ID: 1078707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.
    Weiss HJ; Sussman II; Hoyer LW
    J Clin Invest; 1977 Aug; 60(2):390-404. PubMed ID: 17621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.
    Asatiani E; Kessler CM;
    Haemophilia; 2007 Nov; 13(6):685-96. PubMed ID: 17973844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogens and surgery in women with von Willebrand's disease.
    Alperin JB
    Am J Med; 1982 Sep; 73(3):367-71. PubMed ID: 6981997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined clotting factor deficiencies: experience at a single hemophilia treatment center.
    O'Brien SH; Ritchey AK; Ragni MV
    Haemophilia; 2007 Jan; 13(1):26-9. PubMed ID: 17212721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery in patients with von Willebrand's disease.
    Blombäck M; Johansson G; Johnsson H; Swedenborg J; Wabö E
    Br J Surg; 1989 Apr; 76(4):398-400. PubMed ID: 2785837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thrombosis following the use of intermediate purity FVIII concentrate to treat patients with von Willebrand's disease.
    Makris M; Colvin B; Gupta V; Shields ML; Smith MP
    Thromb Haemost; 2002 Sep; 88(3):387-8. PubMed ID: 12353065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor VIII competitive enzyme assay: observations in von Willebrand's variants and hemophiliacs.
    Yorde LD; Yorde DE; Sasse EA; Hussey CV
    Clin Physiol Biochem; 1984; 2(6):298-303. PubMed ID: 6440727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and safety of the factor VIII/von Willebrand factor concentrate BIOSTATE in patients with von Willebrand's disease: a prospective multi-centre study.
    Dunkley S; Baker RI; Pidcock M; Price J; Seldon M; Smith M; Street A; Maher D; Barrese G; Stone C; Lloyd J
    Haemophilia; 2010 Jul; 16(4):615-24. PubMed ID: 20331755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective periodontal treatment in a patient with type IIA von Willebrand's disease: report of a case.
    Izumi Y; Taniguchi T; Maruyama Y; Sueda T
    J Periodontol; 1999 May; 70(5):548-53. PubMed ID: 10368060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Von Willebrand disease - the 'Dos' and 'Don'ts' in surgery.
    Miesbach W; Berntorp E
    Eur J Haematol; 2017 Feb; 98(2):121-127. PubMed ID: 27622750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion medicine management for reconstructive spinal repair in a patient with von Willebrand's disease and a history of heavy surgical bleeding.
    Bolan CD; Rick ME; Polly DW
    Spine (Phila Pa 1976); 2001 Dec; 26(23):E552-6. PubMed ID: 11725256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease.
    Brinkhous KM
    Wien Klin Wochenschr; 1982 Oct; 94(19):509-14. PubMed ID: 6818773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of severe menorrhagia at menarche with recombinant factor VIIa in an adolescent girl with type III von Willebrand's disease.
    Gokcebay DG; Culha V; Yarali N; Ozbek NY
    Blood Coagul Fibrinolysis; 2018 Jul; 29(5):469-471. PubMed ID: 29750671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.